IDRA - イデラ・ファ―マシュ―ティカルズ (Idera Pharmaceuticals Inc.) イデラ・ファ―マシュ―ティカルズ

 IDRAのチャート


 IDRAの企業情報

symbol IDRA
会社名 Idera Pharmaceuticals Inc (イデラ・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 イデラ・ファーマシューティカルズ(Idera Pharmaceuticals Inc.)は腫瘍学及び希少疾患の治療薬の発見・開発・商業化に焦点を当てた臨床段階のバイオ医薬企業である。同社はトール様受容体(TLR)ターゲティング技術および第3世代アンチセンス(3GA)技術を含む薬物候補を設計・開発するために、2つの創薬技術プラットフォームを利用する。TLR技術を使用して、同社は特定のTLRの活性を調節することによって作用する合成オリゴヌクレオチドに基づく薬物候補を設計する。3GA技術を用いて、病気を引き起こす遺伝子に関連するメッセンジャーリボ核酸(mRNA)をオフにする薬剤候補を開発する。同社の薬物候補には、IMO-8400、IMO-2125およびIMO-9200が含まれる。同社は、TLRアンタゴニストおよびアゴニストを、標的化TLRの活性を調節することによって作用させるように設計した。同社は病気を引き起こす遺伝子に関連するmRNAを消す3GA技術を開発する。   イデラ・ファ―マシュ―ティカルズは、臨床段階の米国バイオテクノロジ―企業。自己免疫疾患の治療のためと特定の遺伝的に定義されたフォ―ムのB細胞リンパ腫の治療製薬の開発に従事する。癌、感染症やアルツハイマ―病などの分野でTLR7、TLR8、およびTLR9作用薬を含むワクチンの製品を、研究・開発、商業化する。   Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.
本社所在地 167 Sidney Street Cambridge MA 02139 USA
代表者氏名 James A. Geraghty ジェームズ・A.グラガッティ
代表者役職名 Independent Chairman of the Board
電話番号 +1 484-348-1600
設立年月日 32629
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数
url www.iderapharma.com
nasdaq_url https://www.nasdaq.com/symbol/idra
adr_tso
EBITDA EBITDA(百万ドル) -65.52800
終値(lastsale) 8.71
時価総額(marketcap) 236684259.63
時価総額 時価総額(百万ドル) 191.30390
売上高 売上高(百万ドル) 0.75500
企業価値(EV) 企業価値(EV)(百万ドル) 97.25790
当期純利益 当期純利益(百万ドル) -65.58200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Idera Pharmaceuticals Inc revenues decreased 26% to $418K. Net loss decreased 1% to $36.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and development decrease of 17% to $24.4M (expense) Interest income increase of 62% to $482K (income).

 IDRAのテクニカル分析


 IDRAのニュース

   Idera Pharmaceuticals Inc (IDRA): Hedge Funds Are Nibbling On  2020/06/22 03:13:49 Yahoo Finance
In this article we will check out the progression of hedge fund sentiment towards Idera Pharmaceuticals Inc (NASDAQ:IDRA) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research
   Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update  2020/04/30 20:35:00 GlobeNewswire
Financial Resources Through Critical Catalyst of Phase 3 ORR Readout and Potentially Beyond
   Idera Pharmaceuticals EPS misses by $1.42  2020/03/12 11:44:31 Seeking Alpha
Idera Pharmaceuticals (NASDAQ:IDRA): Q4 Non-GAAP EPS of -$0.40; GAAP EPS of -$1.76 misses by $1.42. Press Release
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.
   Idera Confirms Private Placement of up to US$97.7 Million  2019/12/23 14:45:38 Investing News Network
Idera Pharmaceuticals announced today it is entering into an agreement for gross proceeds of US$3.9 million. The post Idera Confirms Private Placement of up to US$97.7 Million appeared first on Investing News Network .
   Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update  2020/04/30 20:35:00 GlobeNewswire
Financial Resources Through Critical Catalyst of Phase 3 ORR Readout and Potentially Beyond
   Idera Pharmaceuticals EPS misses by $1.42  2020/03/12 11:44:31 Seeking Alpha
Idera Pharmaceuticals (NASDAQ:IDRA): Q4 Non-GAAP EPS of -$0.40; GAAP EPS of -$1.76 misses by $1.42. Press Release
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.
   Idera Confirms Private Placement of up to US$97.7 Million  2019/12/23 14:45:38 Investing News Network
Idera Pharmaceuticals announced today it is entering into an agreement for gross proceeds of US$3.9 million. The post Idera Confirms Private Placement of up to US$97.7 Million appeared first on Investing News Network .
   The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win  2019/12/12 12:38:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.
   Idera Pharmaceuticals EPS misses by $1.42  2020/03/12 11:44:31 Seeking Alpha
Idera Pharmaceuticals (NASDAQ:IDRA): Q4 Non-GAAP EPS of -$0.40; GAAP EPS of -$1.76 misses by $1.42. Press Release
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.
   Idera Confirms Private Placement of up to US$97.7 Million  2019/12/23 14:45:38 Investing News Network
Idera Pharmaceuticals announced today it is entering into an agreement for gross proceeds of US$3.9 million. The post Idera Confirms Private Placement of up to US$97.7 Million appeared first on Investing News Network .
   The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win  2019/12/12 12:38:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.
   The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint  2019/12/11 12:21:31 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL )(agreed to be bought by Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Bristol-Myers Squibb Co (NYSE: BMY )(reacted to ASH presentation) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GlaxoSmithKline plc (NYSE: GSK ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) The Medicines Company (NASDAQ: MDCO ) Merck & Co.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 イデラ・ファ―マシュ―ティカルズ IDRA Idera Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)